tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Terence Flynn, 155 are a HOLD (39.54%), 38 are a SELL (9.69%), 199 are a BUY (50.77%).
Analyst Terence Flynn, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 68.86% that have a potential upside of 34.89% achieved within 236 days. Previously, Terence Flynn worked at GOLDMAN SACHS.
Terence Flynn’s has documented 822 price targets and ratings displayed on 41 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALMS, Alumis Common Stock at 20-Mar-2026.
Analyst best performing recommendations are on TBIO (TELESIS BIO).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/13/2023. The price target of $20 was fulfilled within 2 days with a profit of $3.41 (20.55%) receiving and performance score of 102.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Sep-2025
$43
$14.85 (52.75%)
$37
23 days ago
(26-Feb-2026)
0/4 (0%)
$11.96 (38.53%)
Hold Since 02-Jan-2024
$34
$5.85 (20.78%)
$34
1 months 1 days ago
(20-Feb-2026)
10/13 (76.92%)
$2.16 (6.78%)
53
Buy Since 11-Feb-2025
$45
$16.85 (59.86%)
$52
4 months 8 days ago
(13-Nov-2025)
0/3 (0%)
$13.99 (45.11%)
Buy Since 28-May-2025
$44
$15.85 (56.31%)
$45
4 months 20 days ago
(29-Oct-2025)
0/4 (0%)
$12.55 (39.90%)
Buy Since 17-Feb-2022
$45
$16.85 (59.86%)
$40
4 months 22 days ago
(27-Oct-2025)
24/36 (66.67%)
$15.28 (51.41%)
354
Which stock is Terence Flynn is most bullish on?
Which stock is Terence Flynn is most reserved on?
What Year was the first public recommendation made by Terence Flynn?
